Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Vertex and CRISPR Therapeutics Granted Historic Approval for CASGEVY™, the World's First CRISPR/Cas9 Gene-Edited Therapy, by UK MHRA to Combat Sickle Cell Disease and Beta Thalassemia

 - First regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell...

November 17, 2023 | Friday | News
FDA Clears Solid Biosciences' Gene Therapy for Duchenne Muscular Dystrophy

Planning to initiate Phase 1/2 trial in pediatric DMD Patients – – First cohort to study patients 4 to < 6 years of age –   &l...

November 15, 2023 | Wednesday | News
Cellares and Cabaletta Bio Join Forces for Automated Manufacturing of CABA-201 on Cell Shuttle Platform

-Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, an...

November 07, 2023 | Tuesday | News
Senti Bio Collaborates with Celest Therapeutics to Advance SENTI-301A in China

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 202...

November 07, 2023 | Tuesday | News
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics

Novogene is a leading provider of genomic services and solutions offering extensive next generation sequencing (NGS) capacity and bioinformatics expertise....

November 06, 2023 | Monday | News
Fluor Empowers Bayer's Cell Therapy Innovation with State-of-the-Art Facility in Berkeley, California

Fluor Corporation  announced that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Co...

October 19, 2023 | Thursday | News
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics

Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...

October 18, 2023 | Wednesday | News
Revvity and Element Biosciences Collaborate to Enhance NGS Research Workflow

“This collaboration between Revvity and Element Biosciences seeks to elevate the overall customer experience by providing compelling application-spec...

October 17, 2023 | Tuesday | News
AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...

October 13, 2023 | Friday | News
Multiply Labs Teams Up with UC San Francisco, Cytiva, Thermo Fisher, and Charles River for Robotic Cell Therapy Proof-of-Concept

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs (including but not limited to...

October 12, 2023 | Thursday | News
Be The Match BioTherapies® & Cryoport Join Forces for Cell & Gene Therapy Advancement

 Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport...

October 10, 2023 | Tuesday | News
BIOVECTRA Partners with Acuitas Therapeutics for Innovative LNP Delivery System in mRNA Therapy Production

BIOVECTRA and Acuitas Therapeutics, Inc.  announced that they have entered into a technology transfer service agreement under which BIOVECTRA will acc...

October 06, 2023 | Friday | News
MediciNova Receives Gene Therapy Milestone Payment

The milestone payment of $1 million is the result of the successful achievement of a clinical development milestone for a gene therapy product based o...

October 05, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in